In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

Innovative, nontoxic molecules developed by a research team at the Institut national de la recherche scientifique (INRS) ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Humanity, according to Michael Zey, a noted sociologist, has the wherewithal to controlling its own destiny, owing to ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah biochemist whose discoveries helped make the drug happen worries government cuts ...

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.

FDA approves twice-a-year HIV prevention drug that could help end the virus worldwide It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.